Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Iradimed Corp Company Profile (NASDAQ:IRMD)

Consensus Ratings for Iradimed Corp (NASDAQ:IRMD) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (93.32% upside)

Analysts' Ratings History for Iradimed Corp (NASDAQ:IRMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/11/2014Roth CapitalInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/22/2012 forward)
Discuss Iradimed Corp